Concord Biotech Limited (CONCORDBIO)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 194.83 262.35 240.80 318.97 215.80 310.18 244.22 429.88 203.99 247.06 278.13
YOY Revenue Growth % - - - - 10.77% 18.23% 1.42% 34.77% -5.47% -20.35% 13.89%
Other Income 6.65 8.13 8.19 10.81 10.31 10.03 14.73 9.38 13.68 13.43 10.08
Total Income 201.48 270.47 248.98 329.78 226.11 320.21 258.95 439.27 217.67 260.49 288.22
Total Expenses + 121.75 132.29 135.17 151.51 141.26 165.24 154.83 254.17 160.43 174.97 194.64
Cost of Materials Consumed 39.48 42.00 47.39 55.67 55.03 68.05 60.96 80.27 59.91 57.30 66.59
Employee Benefit Expense 28.25 30.17 30.67 33.96 31.66 33.66 34.64 38.97 37.90 43.18 44.09
Other Expenses 54.02 60.12 57.11 61.88 54.56 63.52 59.23 72.00 59.59 64.32 65.66
Operating Profit 73.07 130.06 105.62 167.46 74.54 144.94 89.39 175.71 43.56 72.09 83.49
OPM % 37.5% 49.6% 43.9% 52.5% 34.5% 46.7% 36.6% 40.9% 21.4% 29.2% 30%
Profit Before Tax + 65.01 113.18 100.08 130.92 78.17 133.29 99.32 185.09 57.24 85.52 90.30
Tax Expense 16.54 28.68 25.53 33.70 19.93 34.59 25.23 43.16 14.67 22.62 22.51
Tax % 25.4% 25.3% 25.5% 25.7% 25.5% 26% 25.4% 23.3% 25.6% 26.5% 24.9%
Profit After Tax 48.47 84.49 74.55 97.21 58.24 98.70 74.09 141.94 42.57 62.90 67.78
EPS (Basic) 4.63 8.08 7.13 9.29 5.57 9.43 7.08 13.57 4.07 6.01 6.48

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024
Revenue from Operations 1,200.09 1,016.94
YOY Revenue Growth % 18.01% -
Other Income 44.45 33.78
Total Income 1,244.53 1,050.72
Total Expenses + 748.66 540.72
Cost of Materials Consumed 264.31 184.54
Employee Benefit Expense 138.93 123.05
Other Expenses 249.31 233.14
Operating Profit 451.43 476.22
OPM % 37.6% 46.8%
Profit Before Exceptional 495.88 409.19
Exceptional Items 0.00 0.00
Profit Before Tax + 495.88 409.19
Tax Expense 122.91 104.46
Tax % 24.8% 25.5%
Profit After Tax 372.96 304.73
EPS (Basic) 35.65 29.13

Balance Sheet

Particulars Mar 2025 Mar 2024
ASSETS
Non-Current Assets + 898.94 803.08
Property, Plant & Equipment 791.81 571.73
Capital Work in Progress 50.13 211.48
Non-Current Investments 18.65 0.67
Goodwill 0.00 0.00
Other Intangible Assets 2.28 3.58
Current Assets + 1,135.24 896.23
Inventories 239.67 207.95
Trade Receivables 521.65 349.61
Cash and Cash Equivalents 0.90 15.14
Current Investments 316.54 243.70
LIABILITIES & EQUITY
Total Equity 0.00 0.00
Equity Share Capital 10.46 10.46
Other Equity 1,802.18 1,514.79
Non-Current Liabilities 37.47 31.91
Current Liabilities 184.06 142.16
Total Liabilities 221.53 174.06

Cash Flow Statement

Particulars Mar 2025 Mar 2024
Cash from Operating Activities 244.52 265.47
Cash from Investing Activities -159.99 -154.61
Cash from Financing Activities -98.77 -99.21
Net Increase/Decrease in Cash -14.24 11.64